Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2015, Article ID 872915, 5 pages
http://dx.doi.org/10.1155/2015/872915
Case Report

Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient with Intracranial Metastatic Renal Cell Carcinoma

1Gamma Knife of Spokane, 910 W 5th Avenue, Suite 102, Spokane, WA 99204, USA
2Cancer Care Northwest, 910 W 5th Avenue, Suite 102, Spokane, WA 99204, USA
3University of Washington School of Medicine, 1959 NE Pacific Street, Seattle, WA 98195, USA
4Inland Neurosurgery & Spine Associates, 105 W 8th Avenue, Suite 200, Spokane, WA 99204, USA
5Rockwood Clinic, 801 W 5th Avenue, Suite 525, Spokane, WA 99204, USA

Received 28 August 2015; Accepted 13 October 2015

Academic Editor: Mehmet Turgut

Copyright © 2015 Ethan A. Ferrel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Posner, “Management of brain metastases,” Revue Neurologique, vol. 148, no. 6-7, pp. 477–487, 1992. View at Google Scholar · View at Scopus
  2. S. R. Rapp, L. Doug Case, A. Peiffer et al., “Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial,” Journal of Clinical Oncology, vol. 33, no. 15, pp. 1653–1659, 2015. View at Google Scholar
  3. R. A. Patchell, “The management of brain metastases,” Cancer Treatment Reviews, vol. 29, no. 6, pp. 533–540, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. N. F. Marko, L. Angelov, S. A. Toms et al., “Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases,” World Neurosurgery, vol. 73, no. 3, pp. 186–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. W. E. Samlowski, G. A. Watson, M. Wang et al., “Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS),” Cancer, vol. 109, no. 9, pp. 1855–1862, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Soffietti, R. Ruda, and R. Mutani, “Management of brain metastases,” Journal of Neurology, vol. 249, no. 10, pp. 1357–1369, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. H. Kim, J. W. Kim, H. T. Chung, S. H. Paek, D. G. Kim, and H. W. Jung, “Brain metastasis from renal cell carcinoma,” Progress in Neurological Surgery, vol. 25, pp. 163–175, 2012. View at Publisher · View at Google Scholar
  8. J. W. Clarke, S. Register, J. M. McGregor et al., “Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis,” American Journal of Clinical Oncology, vol. 33, no. 1, pp. 70–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Fokas, M. Henzel, K. Hamm, G. Surber, G. Kleinert, and R. Engenhart-Cabillic, “Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?” Strahlentherapie und Onkologie, vol. 186, no. 4, pp. 210–217, 2010. View at Publisher · View at Google Scholar
  10. H. Saitoh, M. Nakayama, K. Nakamura, and T. Satoh, “Distant metastasis of renal adenocarcinoma in nephrectomized cases,” Journal of Urology, vol. 127, no. 6, pp. 1092–1095, 1982. View at Google Scholar · View at Scopus
  11. H. T. Cohen and F. J. McGovern, “Renal-cell carcinoma,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2477–2490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Nieder, W. Berberich, and K. Schnabel, “Tumor-related prognostic factors for remission of brain metastases after radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 39, no. 1, pp. 25–30, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. N. B. Dye, V. Gondi, and M. P. Mehta, “Strategies for preservation of memory function in patients with brain metastases,” Chinese Clinical Oncology, vol. 4, no. 2, article 24, 2015. View at Publisher · View at Google Scholar
  14. E. L. Chang, J. S. Wefel, K. R. Hess et al., “Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial,” The Lancet Oncology, vol. 10, no. 11, pp. 1037–1044, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. A. Brown, A. L. Asher, K. V. Ballman et al., “NCCTG N0574 (Alliance): a phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases,” Journal of Clinical Oncology, vol. 33, no. 15, abstract LBA4, 2015. View at Google Scholar
  16. T. Shuto, S. Matsunaga, J. Suenaga, S. Inomori, and H. Fujino, “Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of gamma knife surgery or craniotomy for control of growth and peritumoral edema,” Journal of Neuro-Oncology, vol. 98, no. 2, pp. 169–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Shuto, S. Matsunaga, S. Inomori, and H. Fujino, “Efficacy of gamma knife surgery for control of peritumoral oedema associated with metastatic brain tumours,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 9, pp. 1061–1065, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. P. Sheehan, M.-H. Sun, D. Kondziolka, J. Flickinger, and L. D. Lunsford, “Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control,” Journal of Neurosurgery, vol. 98, no. 2, pp. 342–349, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Muacevic, F. W. Kreth, A. Mack, J.-C. Tonn, and B. Wowra, “Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma,” Minimally Invasive Neurosurgery, vol. 47, no. 4, pp. 203–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. W. Powell, C. T. Chung, H. R. Shah et al., “Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma,” Journal of neurosurgery, vol. 109, supplement, pp. 122–128, 2008. View at Google Scholar · View at Scopus
  21. T. S. Hong, W. A. Tomé, L. Hayes et al., “Acute sequelae of stereotactic radiosurgery,” in Radiosurgery, vol. 5, pp. 38–45, Karger, Basel, Switzerland, 2004. View at Google Scholar
  22. A. L. Elaimy, A. R. MacKay, W. T. Lamoreaux et al., “Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors,” World Neurosurgery, vol. 75, no. 5-6, pp. 673–683, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Kano, A. Iyer, D. Kondziolka, A. Niranjan, J. C. Flickinger, and L. D. Lunsford, “Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases,” Neurosurgery, vol. 69, no. 6, pp. 1232–1239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Rades, S. Huttenlocher, N. Gebauer et al., “Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma,” Anticancer Research, vol. 35, no. 6, pp. 3571–3574, 2015. View at Google Scholar
  25. J. G. Lorenzoni, D. Devriendt, N. Massager et al., “Brain stem metastases treated with radiosurgery: prognostic factors of survival and life expectancy estimation,” Surgical Neurology, vol. 71, no. 2, pp. 188–196, 2009. View at Publisher · View at Google Scholar · View at Scopus